Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs KKR & Co Inc (KKR) Price & Performance

CVS Health CorpTrade
KKR & Co IncTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs KKR & Co Inc — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while KKR & Co Inc trades at $90 (market cap $80.39B). The key difference: CVS Health Corp is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (3.03%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and KKR & Co Inc for 67 Days on average.

CVSKKR
Market Cap
$112.29B$80.39B
Volume
7,763,6766,517,705
Sector
HealthFinancials
52-Week High
$110.60$142.75
52-Week Low
$70.08$83.88
Typical Hold Time
83 Days67 Days
Enterprise Value
$174.64B$2.95B
Dividend Yield
3.03%0.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.

The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.

KKR & Co Inc

KKR trades at $89.67, down 1.1% on the day, with a bearish technical signal but strong analyst support. Recent earnings show beats in Q1 and Q2 2026, with revenue of $19.21B in 2025 and net income of $2.37B. The stock is supported by a consensus price target of $123.30, indicating significant upside potential. News highlights active deal-making, including joint ventures and asset sales, reinforcing its global investment firm strategy.

The outlook for KKR is positive based on robust fundamentals and analyst optimism, though technical indicators suggest near-term caution. Investment opportunities include potential price appreciation toward the consensus target and ongoing strategic investments. Risks involve market volatility, execution of large-scale deals, and macroeconomic factors affecting asset management returns.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

KKR
100% Buy0% Sell
Avg holding period · 67 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About KKR & Co Inc

KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.

Read more on KKR →